Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Uber
UBER
|
+$1.02B |
| 3 |
Apple
AAPL
|
+$906M |
| 4 |
Broadcom
AVGO
|
+$749M |
| 5 |
NVIDIA
NVDA
|
+$732M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$1.52B |
| 2 |
Danaher
DHR
|
+$586M |
| 3 |
VMW
VMware, Inc
VMW
|
+$474M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$450M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$388M |
Sector Composition
| 1 | Technology | 28.87% |
| 2 | Financials | 12.76% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 11% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Fennec Pharmaceuticals
FENC
$252M
| $2.45M | ﹤0.01% |
218,590
+12,391
| +6% | +$139K |
|
3027
The RealReal
REAL
$1.08B
| $2.45M | ﹤0.01% |
1,219,378
+37,274
| +3% | +$74.9K |
|
3028
Cadiz
CDZI
$312M
| $2.44M | ﹤0.01% |
872,832
+38,031
| +5% | +$106K |
|
3029
NET Power
NPWR
$165M
| $2.44M | ﹤0.01% |
241,679
+9,382
| +4% | +$94.8K |
|
3030
Hyliion Holdings
HYLN
$281M
| $2.43M | ﹤0.01% |
2,989,913
+127,992
| +4% | +$104K |
|
|
AKYA
3031
DELISTED
Akoya BioSciences
AKYA
| $2.43M | ﹤0.01% |
498,175
+32,094
| +7% | +$157K |
|
3032
LifeMD
LFMD
$269M
| $2.42M | ﹤0.01% |
292,079
+29,351
| +11% | +$243K |
|
3033
ReNew
RNW
$2.78B
| $2.42M | ﹤0.01% |
315,999
-18,024
| -5% | -$138K |
|
3034
Maui Land & Pineapple Co
MLP
$354M
| $2.42M | ﹤0.01% |
152,026
+5,003
| +3% | +$79.5K |
|
3035
Marine Products Corp
MPX
$318M
| $2.42M | ﹤0.01% |
211,821
+16,293
| +8% | +$186K |
|
3036
Alliance Resource Partners
ARLP
$2.93B
| $2.41M | ﹤0.01% |
113,784
+4,442
| +4% | +$94.1K |
|
3037
Latham Group
SWIM
$932M
| $2.39M | ﹤0.01% |
908,421
+45,749
| +5% | +$120K |
|
3038
Petrobras
PBR
$82.7B
| $2.39M | ﹤0.01% |
149,348
| – | – |
|
3039
TORM
TRMD
$2.23B
| $2.36M | ﹤0.01% |
77,521
+252
| +0.3% | +$7.66K |
|
3040
X4 Pharmaceuticals
XFOR
$75M
| $2.35M | ﹤0.01% |
93,415
+5,318
| +6% | +$134K |
|
3041
Biote Corp
BTMD
$108M
| $2.33M | ﹤0.01% |
472,190
+143,394
| +44% | +$709K |
|
3042
Angi Inc
ANGI
$784M
| $2.33M | ﹤0.01% |
93,614
+9,421
| +11% | +$235K |
|
|
BCOV
3043
DELISTED
Brightcove, Inc.
BCOV
| $2.33M | ﹤0.01% |
898,347
+32,015
| +4% | +$82.9K |
|
3044
Viper Energy
VNOM
$6.65B
| $2.32M | ﹤0.01% |
73,988
+10,469
| +16% | +$329K |
|
3045
Telos
TLS
$500M
| $2.32M | ﹤0.01% |
634,531
+32,356
| +5% | +$118K |
|
3046
Contango ORE
CTGO
$285M
| $2.31M | ﹤0.01% |
127,623
+50,592
| +66% | +$916K |
|
3047
Alto Ingredients
ALTO
$88.2M
| $2.31M | ﹤0.01% |
867,972
+55,811
| +7% | +$148K |
|
3048
TELA Bio
TELA
$63M
| $2.3M | ﹤0.01% |
346,662
+11,517
| +3% | +$76.3K |
|
|
QIPT
3049
Quipt Home Medical
QIPT
$116M
| $2.3M | ﹤0.01% |
450,911
+9,899
| +2% | +$50.4K |
|
3050
Invivyd
IVVD
$237M
| $2.29M | ﹤0.01% |
581,090
+37,430
| +7% | +$148K |
|